PhaseBio Announces Interim Analysis of REVERSE-IT Phase 3 Trial Accepted for Late Breaking Science Presentation at the American Heart Association Scientific Sessions 2021

Stock Information for PhaseBio Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.